2024
|
Invention
|
Protease inhibitors as antivirals.
Provided herein, inter alia, are compounds, pharmaceutical co... |
2022
|
Invention
|
Heterocyclic compounds and uses thereof.
The present disclosure relates to pharmaceutical compou... |
|
Invention
|
Heterocyclic compounds and uses thereof. The present disclosure relates to pharmaceutical compoun... |
|
Invention
|
Protease inhibitors as antivirals. Provided herein, inter alia, are compounds, pharmaceutical com... |
|
Invention
|
Protease inhibitors as antivirals. inter aliainter alia, are compounds, pharmaceutical compositio... |
2020
|
Invention
|
Heterocyclic compounds and uses as anticancer agents. The present disclosure provides pharmaceuti... |
2019
|
Invention
|
Egfr modulators and uses thereof. The present invention relates to certain pyrrolopyrimidine deri... |
2018
|
Invention
|
Process for manufacture of (s)-n-(3-((2-((4-((1-acetylpyrrolidin-3-yl)(methyl)amino)phenyl)amino)... |
|
Invention
|
Heterocyclic compounds and uses thereof. The present invention relates to pharmaceutical compound... |
2017
|
Invention
|
Pharmaceutical composition comprising n-(3-((2-((3-fluoro-4-(4-methylpiperazin-1-yl phenyl)amino)... |
|
Invention
|
Pyrrolopyrimidine compounds as inhibitors of protein kinases. The present invention relates to ce... |
2016
|
Invention
|
Pharmaceutical salts, physical forms, and compositions of pyrrolopyrimidine kinase inhibitors, an... |
2013
|
Invention
|
Pyrrolo[2,3-d]pyrimidine compounds as inhibitors of protein kinases. The present invention relate... |
2011
|
Invention
|
Heterocyclic compounds and uses as anticancer agents.
Novel compounds having a fused bicyclic he... |
2009
|
Invention
|
Synthetic process for anticancer drug fluorapacin and trisulfide derivatives. The invention provi... |
|
Invention
|
Substituted organosulfur compounds and methods of using thereof. The present invention provides s... |
2008
|
Invention
|
Heterocyclic compounds and uses as anticancer agents. Novel compounds having a fused bicyclic het... |